208 related articles for article (PubMed ID: 26829519)
21. Stachys lavandulifolia Vahl. exhibits promising in vitro and in vivo antileishmanial activity against Leishmania major infection.
Alanazi AD; Albalawi AE; Almohammed HI; Shater AF
Trop Biomed; 2022 Sep; 39(3):412-420. PubMed ID: 36214438
[TBL] [Abstract][Full Text] [Related]
22. Meglumine Antimoniate (Glucantime) Causes Oxidative Stress-Derived DNA Damage in BALB/c Mice Infected by Leishmania (Leishmania) infantum.
Moreira VR; de Jesus LCL; Soares RP; Silva LDM; Pinto BAS; Melo MN; Paes AMA; Pereira SRF
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320726
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of meglumine antimoniate against L. tropica in a recently emerged focus of cutaneous leishmaniasis in Birjand, eastern Islamic Republic of Iran.
Karamian M; Bojd MS; Salehabadi A; Hemmati M; Barati DA
East Mediterr Health J; 2015 Jun; 21(4):280-6. PubMed ID: 26077523
[TBL] [Abstract][Full Text] [Related]
24. Fe3O4
Albalawi AE; Khalaf AK; Alyousif MS; Alanazi AD; Baharvand P; Shakibaie M; Mahmoudvand H
Biomed Pharmacother; 2021 Jul; 139():111566. PubMed ID: 33839494
[TBL] [Abstract][Full Text] [Related]
25. Early enlargement of an ulcerated area during leishmaniasis treatment with meglumine antimoniate in Brazil.
Romero GA; Molinet FJ; Noronha EF
Trans R Soc Trop Med Hyg; 2013 Apr; 107(4):266-8. PubMed ID: 23315614
[TBL] [Abstract][Full Text] [Related]
26. Study of the
Azadi R; Alipour-Talesh G; Yazdanpanah MJ; Alavizadeh SH; Maleki M; Banihashemi M; Jaafari MR
J Vector Borne Dis; 2020; 57(1):78-84. PubMed ID: 33818460
[TBL] [Abstract][Full Text] [Related]
27. Responses of Leishmania (Viannia) braziliensis cutaneous infection to N-methylglucamine antimoniate in the rhesus monkey (Macaca mulatta) model.
Teva A; Porrozzi R; Oliveira-Neto MP; Grimaldi GJ
J Parasitol; 2005 Aug; 91(4):976-8. PubMed ID: 17089782
[TBL] [Abstract][Full Text] [Related]
28. Comparative proteomics study on meglumine antimoniate sensitive and resistant Leishmania tropica isolated from Iranian anthroponotic cutaneous leishmaniasis patients.
Hajjaran H; Azarian B; Mohebali M; Hadighi R; Assareh A; Vaziri B
East Mediterr Health J; 2012 Feb; 18(2):165-71. PubMed ID: 22571094
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of antileishmanial activity and cytotoxicity of the extracts of Berberis vulgaris and Nigella sativa against Leishmania tropica.
Mahmoudvand H; Sharififar F; Rahmat MS; Tavakoli R; Dezaki ES; Jahanbakhsh S; Sharifi I
J Vector Borne Dis; 2014 Dec; 51(4):294-9. PubMed ID: 25540961
[TBL] [Abstract][Full Text] [Related]
30. Antileishmanial effect of rapamycin as an alternative approach to control Leishmania tropica infection.
Khadir F; Taheri T; Habibzadeh S; Zahedifard F; Gholami E; Heidari-Kharaji M; Oryan A; Rafati S
Vet Parasitol; 2019 Dec; 276():108976. PubMed ID: 31739256
[TBL] [Abstract][Full Text] [Related]
31. Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.
Azeredo-Coutinho RB; Mendonça SC; Callahan H; Portal AC; Max G
J Parasitol; 2007 Jun; 93(3):688-93. PubMed ID: 17626365
[TBL] [Abstract][Full Text] [Related]
32. Inhibition by Dications of in vitro growth of Leishmania major and Leishmania tropica: causative agents of old world cutaneous leishmaniasis.
Rosypal AC; Werbovetz KA; Salem M; Stephens CE; Kumar A; Boykin DW; Hall JE; Tidwell RR
J Parasitol; 2008 Jun; 94(3):743-9. PubMed ID: 18605790
[TBL] [Abstract][Full Text] [Related]
33. Leishmania amazonensis: effects of oral treatment with copaiba oil in mice.
dos Santos AO; Costa MA; Ueda-Nakamura T; Dias-Filho BP; da Veiga-Júnior VF; de Souza Lima MM; Nakamura CV
Exp Parasitol; 2011 Oct; 129(2):145-51. PubMed ID: 21771592
[TBL] [Abstract][Full Text] [Related]
34. The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB/c mice.
Moosavian SA; Fallah M; Jaafari MR
Exp Parasitol; 2019 May; 200():30-35. PubMed ID: 30898544
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic Potential of Green Synthesized Copper Nanoparticles Alone or Combined with Meglumine Antimoniate (Glucantime
Albalawi AE; Abdel-Shafy S; Khudair Khalaf A; Alanazi AD; Baharvand P; Ebrahimi K; Mahmoudvand H
Nanomaterials (Basel); 2021 Mar; 11(4):. PubMed ID: 33807273
[TBL] [Abstract][Full Text] [Related]
36. The pentavalent antimonial therapy against experimental Leishmania amazonensis infection is more effective under the inhibition of the NF-κB pathway.
Macedo SR; de Figueiredo Nicolete LD; Ferreira Ados S; de Barros NB; Nicolete R
Int Immunopharmacol; 2015 Sep; 28(1):554-9. PubMed ID: 26218282
[TBL] [Abstract][Full Text] [Related]
37. Expression analysis of activated protein kinase C gene (LACK1) in antimony sensitive and resistant Leishmania tropica clinical isolates using real-time RT-PCR.
Hajjaran H; Kazemi-Rad E; Mohebali M; Oshaghi MA; Khadem-Erfan MB; Hajaliloo E; Reisi Nafchi H; Raoofian R
Int J Dermatol; 2016 Sep; 55(9):1020-6. PubMed ID: 27336481
[TBL] [Abstract][Full Text] [Related]
38. The potential therapeutic role of PTR1 gene in non-healing anthroponotic cutaneous leishmaniasis due to Leishmania tropica.
Sezavar M; Sharifi I; Ghasemi Nejad Almani P; Kazemi B; Davoudi N; Salari S; Salarkia E; Khosravi A; Bamorovat M
J Clin Lab Anal; 2021 Mar; 35(3):e23670. PubMed ID: 33283321
[TBL] [Abstract][Full Text] [Related]
39. Antileishmanial activity of 1,3,4-thiadiazolium-2-aminide in mice infected with Leishmania amazonensis.
Rodrigues RF; Charret KS; da Silva EF; Echevarria A; Amaral VF; Leon LL; Canto-Cavalheiro MM
Antimicrob Agents Chemother; 2009 Feb; 53(2):839-42. PubMed ID: 19015338
[TBL] [Abstract][Full Text] [Related]
40. Glucantime efficacy in the treatment of zoonotic cutaneous leishmaniasis.
Pourmohammadi B; Motazedian MH; Handjani F; Hatam GH; Habibi S; Sarkari B
Southeast Asian J Trop Med Public Health; 2011 May; 42(3):502-8. PubMed ID: 21706927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
